Stage III Ovarian Epithelial Cancer Completed Phase 1 Trials for Topotecan (DB01030)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002913Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerTreatment